Full Text View
Tabular View
No Study Results Posted
Related Studies
Metazym for the Treatment of Patients With Late Infantile Metachromatic Leukodystrophy (MLD)
This study has been completed.
Study NCT00418561   Information provided by Shire Human Genetic Therapies, Inc.
First Received: January 4, 2007   Last Updated: December 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metachromatic Leukodystrophy
Additional conditions recognized in this trial
Leukodystrophy, Metachromatic
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Brain Diseases, Metabolic, Inborn
Central Nervous System Diseases
Demyelinating Diseases
Genetic Diseases, Inborn
Hereditary Central Nervous System Demyelinating Diseases
Lipid Metabolism Disorders
Lipid Metabolism, Inborn Errors
Lipidoses
Lysosomal Storage Diseases
Lysosomal Storage Diseases, Nervous System
Metabolic Diseases
Metabolism, Inborn Errors
Nervous System Diseases
Sphingolipidoses
Sulfatidosis
Interventions listed in this trial
rhASA
Sponsors listed in this trial
Shire Human Genetic Therapies, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services